Improving Organ Donation to Save Thousands of Lives

In 2022, Griffin Catalyst joined with partners to support the Organs Initiative, a coalition leveraging data to drive change with broad bipartisan support. The challenge: To fix a broken, inefficient organ donation system that leads to tens of thousands of healthy organs going unrecovered each year and contributes to 30 Americans dying every day for lack of an available organ. In August 2022, the group achieved the first major overhaul of the organ donation system in 40 years, projected to save over 7,000 lives annually. Almost a year later, in July 2023, Congress unanimously passed legislation to break up the failing national organ monopoly held by the United Network for Organ Sharing (UNOS).
Photo Credit: serts via Getty
A paramedic delivers an organ for transplant in 2020. In 2023, approximately 103,000 people were on the organ waiting list, and the demand for an efficient, improved organ donation system remains critical to saving thousands of lives.

The mismanagement and failures of local organ procurement organizations (OPOs), as well as UNOS — the contractor that manages the national organ transplant system — result in preventable deaths every day. These failures also drive $36 billion per year in Medicare spending for patients on dialysis as they await kidney transplants, representing a full 1% of the entire federal budget. Reforming this system and using data to hold organizations accountable for the first time introduces competition and accountability into an incompetent monopolistic system — and saves lives.

Who We’re Supporting

The Organs Initiative, launched by two nonprofits working together — the Federation of American Scientists and Organize — has driven bipartisan reforms in our national organ donation system. By leveraging data to highlight system failings, increase transparency, and enable the federal government to hold organ contractors accountable for the first time, this work aims to ensure a more effective national system of organ donation on a permanent basis.

In 2022, the group helped to ensure that new data-driven, legally enforceable standards for OPOs went into effect. This critical first step was the capstone to a decades-long fight to hold local organ contractors accountable. Since that time, bipartisan Congressional leaders have escalated investigations into systemic waste, fraud, and abuse among federal organ contractors, as well as called for increased transparency in any effort to ensure evidence of effective organ donation services across the country.

The larger goal of the Organs Initiative is to save lives, replacing the current monopolistic structure with a competitive ecosystem in which the performance incentives for organ contractors are more closely aligned with the interests of patients — and in which failing contractors can be readily replaced by higher performers.

Why It Matters

According to a bipartisan report from the Senate Finance Committee, “the U.S. transplant network is not working, putting Americans’ lives at risk.” In 2023, approximately 103,000 people were on the organ waiting list. The Washington Post detailed that UNOS uses “out-of-date technology that has crashed for hours at a time” and has also been responsible for the “careless treatment of donated organs [and] organs lost in transit.” The failures of existing federal organ contractors — funded by the American taxpayer — have meant that thousands of Americans die each year waiting for organs.

The Organs Initiative utilizes a proven, data-driven approach to inject competition and accountability into the system of federal organ donation contractors — all with the goal of saving patients’ lives.

What’s the Impact

The data-driven organ donation policy which went into effect in 2022 is projected to save over 7,000 lives per year and $1 billion per year for the American taxpayer. The legislation unanimously passed in July 2023 lays the groundwork to break up the national organ monopoly which Forbes has described as a “cartel” and will translate to much greater care being provided for generous American donor families and the transplant patients who rely on them. This represents a transformational change in the decades-long fight to hold federal contractors accountable and prevent unnecessary American deaths on the organ waiting list.

A map showing the effectiveness of organ procurement organizations in each state, based on the U.S. Centers for Medicare & Medicaid Services’ three-tiered performance rankings. As of 2021, prior to the enactment of key reforms, the majority of organ procurement organizations nationwide were either underperforming (orange) or failing (red).

Read more from The Washington Post: Congress authorizes overhaul of troubled organ transplant system.

Share

In Brief

December 27, 2023
The success of Operation Warp Speed in 2020, which brought forth an effective COVID-19 vaccine in less than twelve months, was not only a scientific breakthrough but also a demonstration of the power of an approach called an advanced market commitment (AMC). By creating a demand so that pharmaceutical companies could invest in production prior to proving the efficacies of vaccines, this successful approach accelerated time to market and highlighted the opportunity for a class of similar “market-shaping tools” to accelerate progress. To expand this approach, Griffin Catalyst and Schmidt Futures have partnered with the University of Chicago to launch
May 31, 2024
Launched in 2023, the Miami-Dade Innovation Authority leverages the power of competition and innovation to support start-ups, scale solutions to local problems, and improve lives.
October 28, 2024
Griffin Catalyst provided a seed gift of $2.5 million to accelerate the efforts of Feng Zhang, a faculty member at the Broad Institute of MIT and Harvard, to develop “programmable therapeutics,” an approach that holds promise for revolutionizing medicine by reprogramming cells to cure a wide range of human diseases.
September 4, 2025
A three-year gift to the University of Chicago’s Education Lab has brought an innovative, high-dosage, math tutoring initiative to middle schools in Miami-Dade County in an effort to support and accelerate student learning in the wake of the COVID-19 pandemic. Initial results from the program, which started in spring 2024, are promising, suggesting that this approach can help tackle learning loss and enable students to catch up to grade level.
June 17, 2025
How did the end of the Age of Dinosaurs in Africa impact world history? That’s what researchers aim to uncover during a five-year project of excavation and analysis in the Northern Cape region of South Africa. Their study will explore fossil ecosystems and the biodiversity of sub-Saharan Africa during the Late Cretaceous Period to dramatically expand scientists’ currently limited understanding of this important epoch.
April 17, 2025
Griffin Catalyst is proud to partner with the nonprofit American History Unbound. The collaboration will present dramatic multimedia storytelling about World War I and World War II to audiences in New York and Miami, and nationwide through a documentary being filmed for broadcast on public television later this year, to coincide with Veterans Day. The unique combination of narration and imagery from renowned historian John Monsky, accompanied by music from Broadway stars and the Orchestra of St. Luke’s, brings to life in new ways two of the most pivotal events in the 20th century.
August 30, 2024
Since 2023, Griffin Catalyst has announced transformative gifts to three major health care institutions in Miami. Taken together, the support—totaling $125 million—represents an investment in the future of medical care and research in South Florida.
May 23, 2024
To pay tribute to the nation's most distinguished military heroes—and to unite our country around the values their stories represent—Griffin Catalyst is supporting the National Medal of Honor Museum Foundation with a $30 million gift. The National Medal of Honor Griffin Institute is a key component of a three-pronged, $300 million effort that also includes a new museum in Arlington, Texas, and a new monument in Washington, D.C.
May 20, 2024
In December 2023, Griffin Catalyst and the David Geffen Foundation announced a gift of $400 million to New York's Memorial Sloan Kettering Cancer Center (MSK), one of the most renowned and advanced cancer research and treatment institutions in the world. This landmark gift—the largest donation to the institution in its nearly 150-year history—will allow MSK to significantly expand and upgrade its research, educational, and treatment facilities toward a singular goal: eradicating cancer.